An Act to ensure affordable prescription medications through accountability standards
House: Reporting date extended to Friday, July 31, 2026
Summary
The bill forces manufacturers of certain prescription drugs to provide the state commission with detailed pricing history, research spending and explanations for price changes. The commission can then decide if a drug’s price is unreasonable, issue public recommendations to make the drug cheaper, and impose a civil penalty for non‑compliance. It targets drug makers, patients, health‑care providers and insurers by increasing transparency and accountability.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when H 4489 changes status, plus AI-powered summaries and stage predictions.
Sign up free